Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126848191 | 12684819 | 1 | I | 20160615 | 20160823 | 20160825 | 20160825 | EXP | US-GLAXOSMITHKLINE-US2016123152 | GLAXOSMITHKLINE | 43.00 | YR | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126848191 | 12684819 | 1 | PS | ALLI | ORLISTAT | 1 | UNK | N | 14980 | 21887 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126848191 | 12684819 | 1 | Weight loss diet |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126848191 | 12684819 | HO |
| 126848191 | 12684819 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126848191 | 12684819 | Abdominal pain upper | |
| 126848191 | 12684819 | Back pain | |
| 126848191 | 12684819 | Functional gastrointestinal disorder | |
| 126848191 | 12684819 | Nephrolithiasis | |
| 126848191 | 12684819 | Rectal discharge | |
| 126848191 | 12684819 | Rectal haemorrhage | |
| 126848191 | 12684819 | Scar | |
| 126848191 | 12684819 | Urine odour abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126848191 | 12684819 | 1 | 20160615 | 20160810 | 0 |